Company overview
OrganaBio is a Miami-based CTDMO founded in 2018, providing high-quality cell and gene therapy starting materials like leukopaks, PBMCs, and donor tissues from ethically sourced birth tissue and peripheral blood. It offers clinical cell processing, rapid PBMC isolation, cryopreservation, analytical testing, and autologous apheresis services from facilities in Miami, FL, and Irvine, CA. These vertically integrated solutions support CAR-T, gene therapy, and advanced immunotherapy programs from research to clinical trials.
OrganaBio is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include cell therapy ctdmo, pbmc isolation, cryopreservation services, gene therapy materials, leukopaks supplier.
Structured facts
- Website
- https://www.organabio.com
- Markets served
- United States & Americas
- Keywords
- cell therapy ctdmo, pbmc isolation, cryopreservation services, gene therapy materials, leukopaks supplier
Products & technologies
Therapeutic areas
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What cell therapy starting materials does OrganaBio supply?
- OrganaBio supplies donor-derived materials including leukopaks, PBMCs, immune cell products, and tissue-derived products from ethically sourced birth tissue and peripheral blood, available in research and GMP grades.
- What are OrganaBio's clinical processing capabilities?
- Capabilities include rapid PBMC isolation from whole blood, cryopreservation, analytical testing (cell enumeration, viability, immunophenotyping, stability, endotoxin), autologous apheresis, and cold storage for clinical trial samples.
- Where are OrganaBio's facilities located?
- OrganaBio operates facilities in Miami, FL (headquarters), and Irvine, CA, supporting U.S.-wide clinical trials with East and West Coast coverage.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
